BlackRock Fund Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

BlackRock Fund Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-8,614,625	Closed	-$146M	–	3819
2014 Q4	$146M	Buy	8,614,625 +1,195,031	+16%	+$16.8M	0.04%	651
2014 Q3	$88.4M	Buy	7,419,594 +310,611	+4%	+$2.12M	0.03%	937
2014 Q2	$40.1M	Sell	7,108,983 -453,489	-6%	-$2.09M	0.01%	1545
2014 Q1	$27.8M	Buy	7,562,472 +721,046	+11%	+$2.75M	0.01%	1820
2013 Q4	$23M	Buy	6,841,426 +367,379	+6%	+$1.52M	0.01%	1915
2013 Q3	$27.4M	Buy	6,474,047 +593,598	+10%	+$2.81M	0.01%	1758
2013 Q2	$27.1M	Buy	+5,880,449	New	+$20.2M	0.01%	1630

BlackRock Fund Advisors's AVNR Position: Q1 2015 in Review

BlackRock Fund Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 8,614,625 shares — an estimated $146M sold.

BlackRock Fund Advisors first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $146M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

BlackRock Fund Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
BlackRock Fund Advisors sold 8,614,625 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $146M.
BlackRock Fund Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
BlackRock Fund Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $146M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on BlackRock Fund Advisors's 13F filing for Q1 2015, filed 13 May 2015.